About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Hemodynamic-based Assessment and Management of Cardiogenic Shock

Published:

28 February 2022

Citation:

US Cardiology Review 2022;16:e05.

Cardiogenic Shock: Past, Present, and Future Outlook

Published:

10 February 2022

Citation:

US Cardiology Review 2022;16:e03.

The Contemporary Cardiogenic Shock ‘Playbook’

Published:

26 November 2021

Citation:

US Cardiology Review 2021;15:e24.

Extracorporeal Life Support for Cardiac Arrest and Cardiogenic Shock

Published:

10 November 2021

Citation:

US Cardiology Review 2021;15:e23.